.On the heels of an FDA being rejected for its primary competing Novo Nordisk, Eli Lilly is gaining ...
.Just a couple of months after dosing the initial patient in a phase 2 trial for freshly detected gl...
.Eli Lilly's hunt for being overweight targets has led it to the darker genome. The Big Pharma has p...
.Toolbox Biosciences is proceeding up. The tissue therapy firm has added $325 thousand in ammo along...
.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...
.Aelis Farma's hopes of protecting a quick, good decision on a $one hundred million alternative remi...
.ProKidney has actually stopped some of a pair of phase 3 tests for its tissue therapy for renal con...
.Vaxcyte introduced what analysts named "magnificent" phase 1/2 data for its 31-valent pneumococcal ...
.Recursion has stumbled by means of a very early examination of its own tech-enabled strategy to med...
.Call it a situation of excellent chemistry: Acepodia, a biotech based on Nobel Champion scientific ...